David Loew on acquisition of Epizyme

Epizyme welcome to Ipsen

Back

Epizyme welcome to Ipsen

- 12 August 2022 - 1 mins read
Epizyme welcome to Ipsen

Hear what CEO David Loew has to say about the official close of its acquisition of Epizyme.

How useful was this post?

Click on a star to rate it!

Average rating 0 / 5. Vote count: 0

No votes so far! Be the first to rate this post.

Related stories

Q1 2025 sales update
10 April 2025 0 mins read

Q1 2025 sales update
Financial results for the first nine months of 2024
17 October 2024 0 mins read

Financial results for the first nine months of 2024
Financial results for the first half of 2024
22 July 2024 0 mins read

Financial results for the first half of 2024
Our 2023 Integrated Annual Report is live!
31 May 2024 1 mins read

Our 2023 Integrated Annual Report is live!
Q1 2024 sales update
19 April 2024 0 mins read

Q1 2024 sales update
Applications now open for the 2024 Golden Ticket competition
15 March 2024 2 mins read

Applications now open for the 2024 Golden Ticket competition
FY 2023 results announcement 
08 February 2024 0 mins read

FY 2023 results announcement 
Ipsen sponsors 5 elite athletes on their journeys to the 2024 Paralympics
20 November 2023 1 mins read

Ipsen sponsors 5 elite athletes on their journeys to the 2024 Paralympics
Examining the European Pharma legislation: EFPIA publishes the Dolon Report
10 November 2023 1 mins read

Examining the European Pharma legislation: EFPIA publishes the Dolon Report
Capital Markets Day 2023
03 November 2023 0 mins read

Capital Markets Day 2023